DEXCOM, INC. Amortization of Debt Discount (Premium)
DEXCOM, INC. (DXCM) reported Amortization of Debt Discount (Premium) of $83.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2022-02-14
- DEXCOM, INC. amortization of debt discount (premium) for the quarter ending 2021-12-31 was $16.30M, a 1.81% decline year-over-year.
- DEXCOM, INC. amortization of debt discount (premium) for the quarter ending 2021-09-30 was $22.00M, a 1.38% increase year-over-year.
- DEXCOM, INC. amortization of debt discount (premium) for the quarter ending 2021-06-30 was $22.50M, a 27.84% increase year-over-year.
- DEXCOM, INC. amortization of debt discount (premium) for the quarter ending 2021-03-31 was $22.20M, a 74.80% increase year-over-year.
- DEXCOM, INC. amortization of debt discount (premium) for fiscal 2021 was $83.00M, a 20.99% increase from fiscal 2020.
- DEXCOM, INC. amortization of debt discount (premium) for fiscal 2020 was $68.60M, a 49.78% increase from fiscal 2019.
- DEXCOM, INC. amortization of debt discount (premium) for fiscal 2019 was $45.80M.
- DEXCOM, INC. amortization of debt discount (premium) for fiscal 2018 was -$16.00M, a 270.21% decline from fiscal 2017.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month | Amortization of Debt Discount (Premium) 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $16.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $38.30M derived: sum of 2 quarters · filed 2022-02-14 | $60.80M derived: sum of 3 quarters · filed 2022-02-14 | $83.00M 10-K · filed 2022-02-14 | |
| 2021-09-30 | $22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $44.50M derived: sum of 2 quarters · filed 2021-10-28 | $66.70M 10-Q · filed 2021-10-28 | $83.30M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2021-06-30 | $22.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $44.70M 10-Q · filed 2021-07-29 | $61.30M derived: sum of 3 quarters · filed 2022-02-14 | $83.00M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2021-03-31 | $22.20M 10-Q · filed 2021-04-29 | $38.80M derived: sum of 2 quarters · filed 2022-02-14 | $60.50M derived: sum of 3 quarters · filed 2022-02-14 | $78.10M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-12-31 | $16.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $38.30M derived: sum of 2 quarters · filed 2022-02-14 | $55.90M derived: sum of 3 quarters · filed 2022-02-14 | $68.60M 10-K · filed 2022-02-14 | -$68.60M 10-K · filed 2021-02-11 |
| 2020-09-30 | $21.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $39.30M derived: sum of 2 quarters · filed 2021-10-28 | $52.00M 10-Q · filed 2021-10-28 | $60.80M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-06-30 | $17.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $30.30M 10-Q · filed 2021-07-29 | $39.10M derived: sum of 3 quarters · filed 2022-02-14 | $51.60M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-03-31 | $12.70M 10-Q · filed 2021-04-29 | $21.50M derived: sum of 2 quarters · filed 2022-02-14 | $34.00M derived: sum of 3 quarters · filed 2022-02-14 | $46.30M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2019-12-31 | $8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $21.30M derived: sum of 2 quarters · filed 2022-02-14 | $33.60M derived: sum of 3 quarters · filed 2022-02-14 | $45.80M 10-K · filed 2022-02-14 | $49.60M 10-K · filed 2020-02-13 |
| 2019-09-30 | $12.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $24.80M derived: sum of 2 quarters · filed 2020-10-27 | $37.00M 10-Q · filed 2020-10-27 | $9.70M derived: sum of 4 quarters · filed 2021-02-11 | |
| 2019-06-30 | $12.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $24.50M 10-Q · filed 2020-07-28 | -$2.80M derived: sum of 3 quarters · filed 2021-02-11 | $1.00M derived: sum of 4 quarters · filed 2021-02-11 | |
| 2019-03-31 | $12.20M 10-Q · filed 2020-04-28 | -$15.10M derived: sum of 2 quarters · filed 2021-02-11 | -$11.30M derived: sum of 3 quarters · filed 2021-02-11 | -$7.50M derived: sum of 4 quarters · filed 2021-02-11 | |
| 2018-12-31 | -$27.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$23.50M derived: sum of 2 quarters · filed 2021-02-11 | -$19.70M derived: sum of 3 quarters · filed 2021-02-11 | -$16.00M 10-K · filed 2021-02-11 | $17.90M 10-K · filed 2019-02-21 |
| 2018-09-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $7.60M derived: sum of 2 quarters · filed 2019-11-06 | $11.30M 10-Q · filed 2019-11-06 | $15.00M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-06-30 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $7.50M 10-Q · filed 2019-07-31 | $11.20M derived: sum of 3 quarters · filed 2020-02-13 | $14.80M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-03-31 | $3.70M 10-Q · filed 2019-05-01 | $7.40M derived: sum of 2 quarters · filed 2020-02-13 | $11.00M derived: sum of 3 quarters · filed 2020-02-13 | $13.00M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2017-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $7.30M derived: sum of 2 quarters · filed 2020-02-13 | $9.30M derived: sum of 3 quarters · filed 2020-02-13 | $9.40M 10-K · filed 2020-02-13 | |
| 2017-09-30 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $5.60M derived: sum of 2 quarters · filed 2018-11-06 | $5.70M 10-Q · filed 2018-11-06 | $5.70M derived: sum of 4 quarters · filed 2019-02-21 | |
| 2017-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $2.10M 10-Q · filed 2018-08-01 | $2.10M derived: sum of 3 quarters · filed 2019-02-21 | $2.20M derived: sum of 4 quarters · filed 2019-02-21 | |
| 2017-03-31 | $100.00K 10-Q · filed 2018-05-02 | $100.00K derived: sum of 2 quarters · filed 2019-02-21 | $200.00K derived: sum of 3 quarters · filed 2019-02-21 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $100.00K derived: sum of 2 quarters · filed 2019-02-21 | $100.00K 10-K · filed 2019-02-21 | ||
| 2016-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $100.00K 10-Q · filed 2017-11-01 | |||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-01 | ||||
| 2015-12-31 | $200.00K 10-K · filed 2018-02-27 | ||||
| 2012-12-31 | $0.00 10-K · filed 2013-02-21 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $0.00 derived: sum of 2 quarters · filed 2013-02-21 | $0.00 10-K · filed 2013-02-21 | ||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $0.00 10-Q · filed 2011-11-02 | |||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-03 | ||||
| 2010-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $92.00K derived: sum of 2 quarters · filed 2013-02-21 | $1.10M 10-K · filed 2013-02-21 | $1.06M 10-K · filed 2012-02-23 | |
| 2010-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $1.06M 10-Q · filed 2011-11-02 | |||
| 2010-06-30 | $1.01M 10-Q · filed 2011-08-03 | ||||
| 2009-12-31 | $4.86M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |